advanced age – Page 5 – Communicable Diseases Research

COVID-19 in Recent Lung Transplant Recipients: Clinical Outcomes and Management Strategies

Article

Published on 2022-01-012022-10-05
Journal: Transplantation proceedings [Category] COVID19(2023년), SARS, 바이오마커, 진단, 치료제,

[키워드] advanced age antibody antiviral therapy cause change clinical Clinical course Cohort Comorbidity convalescent plasma COVID-19 COVID-19 infection death disease General population high risk Hospital stay immune incidence Infection infection with COVID-19 Laboratory lung lung transplant management medication Munich obesity one patient outcome outcomes Patient patients Premature receive recent recipient Remdesivir responsible Result risk factor SARS-COV-2 infection severe respiratory failure severity solid organ transplants Strategy suffered susceptible Symptoms the patient the SARS-CoV-2 Transplant Treatment viral infection
[DOI] 10.1016/j.transproceed.2021.12.014 [Article Type] Article

Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation

COVID-19의 면역 기능 장애 및 과염증 치료를 위한 항류마티스 약물의 현명한 사용

Review

Published on 2021-12-172022-09-10
Journal: Turkish Journal of Medical Sciences [Category] SARS, 치료제,

[키워드] administer Administered advanced age affected Antiviral cause of death caused China coronavirus Coronavirus 2019 coronavirus disease Coronavirus disease-19 Corticosteroid Corticosteroids Course COVID-19 cytokine Cytokine storm Cytokines death disease disease course dose drug dysfunction dysregulated earth Economy effective feature global pandemic globe heterogenous hyperinflammation IL-6 immune deficiency immune response immune system immunomodulatory Immunosuppression impairing infected individuals infected patient infected patients Inflammation Inflammatory diseases interferon interferon response interleukin interleukin (IL)-1 life life-threatening Lower respiratory tract morbidity and mortality neutralization Novel coronavirus outcomes pandemic patient population pro-inflammatory cytokine pro-inflammatory cytokines Prognosis respiratory responsible rheumatology SARS-CoV-2 selective Severe infection single person spread to syndrome the disease Treatment Vaccines Viral viral clearance Wuhan
[DOI] 10.3906/sag-2110-179 PMC 바로가기 [Article Type] Review

Differential Impact of COVID-19 Risk Factors on Ethnicities in the United States

Public Health

Published on 2021-12-062022-10-31
Journal: Frontiers in Public Health [Category] COVID-19, SARS,

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications

Supplement Articles

Published on 2021-12-052022-10-29
Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19,

Patients characteristics related to screening mammography cancellation and rescheduling rates during the COVID-19 pandemic

코로나19 팬데믹 기간 동안 유방조영술 검사 취소 및 일정 변경 비율과 관련된 환자 특성

Article

Published on 2021-12-012022-09-11
Journal: Clinical imaging [Category] SARS, 치료기술,

COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age—Propensity Score-Matched Analysis of Austrian National Public Health Institute Data

Article

Published on 2021-11-302022-10-28
Journal: Viruses [Category] COVID-19, MERS, SARS,

Evaluation of the Relationship between Clonal Hematopoiesis and Severe COVID-19 Disease in Rhesus Macaques

Conference abstract

Published on 2021-11-242022-10-05
Journal: Blood [Category] 변종,

[키워드] Acquired advanced age age Analysis Asymptomatic autologous Autopsy BAL benefit Blood clinical manifestation clinical symptom clinically co-morbidities cohort study Concentration Control control group controls COVID-19 COVID-19 disease detectable develop died disease Evidence expand Factor Genes group hallmark Hematopoiesis Human Hyperinflammatory IL-6 IL-6 level IL-8 Infection Inflammation inoculated Laboratory LOF loss of function lung tissue macaque MCP-1 Mild MIP-1b Multiorgan mutant Mutation occur pathophysiological pathophysiology phenotype progenitor cell relationship reported Respiratory failure Respiratory samples rhesus macaque risk risk factor robust Sample size SARS-CoV infection SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA sera severe COVID-19 severe COVID-19 disease severe COVID-19 illness significant difference somatic mutation suggested Symptom TET2 the median therapeutic approaches therapy Vaccine development Viral antigen
[DOI] 10.1182/blood-2021-152628 [Article Type] Conference abstract

A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination

Article

Published on 2021-11-152022-10-28
Journal: Biology [Category] COVID-19,

[키워드] administration advanced age approach benefit booster vaccines calculated can be used CDC Chemotherapy Chronic kidney disease chronic liver disease chronic obstructive Clinical data Clinical risk factors correlated COVID-19 COVID-19 booster vaccine COVID-19 case COVID-19 hospitalization COVID-19 vaccination COVID-19 vaccine COVID-19 vaccine booster prioritization COVID-19 vaccine prioritization criteria diabete dose End-stage renal disease Factors group Health higher risk Hospitalization identify index individual individuals lack leukemia lung cancer mapped Medicare Medicare population Model multivariate logistic regression obesity Predictive Probability pulmonary disease pulmonary fibrosis pulmonary hypertension random reported risk risk factor risk for severe COVID-19 infection risk stratification severe COVID-19 severe COVID-19 disease severe COVID-19 risk model severe disease simple socio-demographic vaccination Vaccine vaccine immunity vulnerability
[DOI] 10.3390/biology10111185 PMC 바로가기 [Article Type] Article

How do patients with chronic illnesses respond to a public health crisis? Evidence from diabetic patients in Japan during the COVID-19 pandemic

Article

Published on 2021-11-152022-10-29
Journal: SSM - Population Health [Category] COVID-19,

[키워드] advanced age affected association changed Characteristics China Chinese Chronic illness Complication contribute coronavirus disease COVID-19 COVID-19 pandemic decrease diabetes diabetic patient Doctor visits early stage East China Sea examined Factor Health healthcare high risk insulin investigated Japan life-threatening Logistic regression moderate occurred pandemic Pandemics Patient performed provide public health public health crisis reaction reduced reducing reduction resources respond response severe COVID-19 Socioeconomic disparities Spread spread of COVID-19 statistical Tokyo unique women
[DOI] 10.1016/j.ssmph.2021.100961 PMC 바로가기 [Article Type] Article

Beneficial Effects of Anticoagulants on the Clinical Outcomes of COVID-19 Patients

Article

Published on 2021-11-132022-10-27
Journal: Antibiotics [Category] COVID-19,

[키워드] 1:1 30-Day mortality acute respiratory distress syndrome Admission advanced age affecting Analysis Anticoagulant calculated Care carried clinical Comorbidity Control control group coronavirus disease COVID-19 COVID-19 patient COVID-19 patients Cox regression analysis death died Effect elevated enoxaparin Factor Frequency group HDU heparin hospital hypercoagulable independent Kaplan–Meier median time moderate Mortality observé outcome Patient patients predictor primary endpoint Probability prophylactic dose prophylactic doses Pulmonary embolism receive reducing mortality Regression model retrospective risk SARS-CoV-2 selected Sepsis severe coronavirus disease severe disease survival survived therapeutic Venous Thromboembolism was performed were used
[DOI] 10.3390/antibiotics10111394 PMC 바로가기 [Article Type] Article